Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients with R/R non-Hodgkin lymphoma (NHL) Meeting Abstract


Authors: Younes, A.; Nowakowski, G.; Rosenthal, A.; Leslie, L.; Tun, H.; Lunning, M.; Isufi, I.; Martell, R.; Patel, K.
Abstract Title: Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients with R/R non-Hodgkin lymphoma (NHL)
Meeting Title: 7th Annual Meeting of the Society of Hematologic Oncology (SOHO 2019)
Keywords: dlbcl; tlr; myd88; nhl; abcl; aggressive b-cell lymphoma; irak4
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 19
Issue: Suppl. 1
Meeting Dates: 2019 Sep 11-14
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2019-09-01
Start Page: S256
End Page: S257
Language: English
ACCESSION: WOS:000483480700208
DOI: 10.1016/j.clml.2019.07.168
PROVIDER: wos
Notes: Meeting Abstract: ABCL-350 -- Source: Wos
Altmetric Score
MSK Authors
  1. Anas Younes
    229 Younes